Episode Details

Our guest today is Dr. Charles Brenner, the Roy J. Carver Chair of Biochemistry at the University of Iowa. Charles is one of the world’s leading experts on nicotinamide adenine dinucleotide, commonly referred to as NAD, which is an essential molecule found in every living cell.  In 2004, he discovered the nicotinamide riboside kinase pathway, which leads to a special form of vitamin B3. We talk to Charles about his research into NAD and why he believes supplementation with NR could help people age better. In addition to his work at the University of Iowa, he is also the chief scientific advisor for ChromaDex,which markets the NR supplement Tru Niagen. In today’s interview, we cover: [00:06:29] How Charles became the first cancer biology graduate student in the biology department at Stanford University. [00:07:51] Charles’ research into nicotinamide adenine dinucleotide (NAD) during his time on the faculty at Thomas Jefferson University. [00:09:15] Charles’ discovery that nicotinamide riboside (NR) is a precursor of NAD. [00:19:47] Why Charles doesn’t use the term “anti-aging.” [00:25:52] The importance of nicotinamide adenine dinucleotide phosphate (NADPH) and its role as the central regulator of reactive oxygen species toxicity. [00:34:56] The circadian rhythms of NAD and the potential benefit of diurnal dosing. [00:38:45] Why skeletal muscle is one of the most sensitive target tissues for the anti-aging effects of NMN. [00:45:42] How the benefits of a ketogenic diet, intermittent fasting, time restricted eating could be related to NAD. [00:47:02] A recent human trial conducted by the University of Coloradothat found Niagen increased NAD+ by 60 percent in healthy middle-aged and older adults after just six weeks. [00:49:19] The optimal dose of NR for humans.